DataBiologics Joins a Nationwide Network Working to Accelerate Transformative Health Solutions
MESA, ARIZONA, September 18, 2024 — DataBiologics, a leader in healthcare data analytics and patient outcomes tracking, announced today that it was selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced Research Projects Agency for Health (ARPA-H).
Based in the Greater Boston area and managed by VentureWell, the Investor Catalyst Hub seeks to accelerate the commercialization of groundbreaking and accessible biomedical solutions. It utilizes an innovative hub-and-spoke model designed to reach a wide range of nonprofit organizations and Minority-Serving Institutions, with the ultimate aim of delivering scalable healthcare outcomes for all Americans.
"We're honored to be selected as a Spoke in the ARPA-H network," said Luke Malanga, Chief Operating Officer of DataBiologics. "This opportunity allows us to further scale our efforts in delivering actionable, data-driven insights to researchers, healthcare providers and patients.”
DataBiologics joins a dynamic nationwide network of organizations aligned to ARPA-H’s overarching mission to improve health outcomes through the following research focus areas: health science futures, proactive health, scalable solutions, and resilient systems. Investor Catalyst Hub spokes represent a broad spectrum of expertise, geographic diversity, and community perspectives.
“Our spoke network embodies a rich and representative range of perspectives and expertise,” said Mark Marino, Vice President of Growth Strategy and Development for VentureWell and Project Director for the Investor Catalyst Hub. “Our spokes comprise a diverse network that will be instrumental in ensuring that equitable health solutions reach communities across every state and tribal nation.”
As an Investor Catalyst Hub spoke, DataBiologics gains access to potential funding and flexible contracting for faster award execution compared to traditional government contracts. Spoke membership also offers opportunities to provide input on ARPA-H challenge areas and priorities, along with access to valuable networking opportunities and a robust resource library.
"DataBiologics is excited to collaborate with other industry leaders in the ARPA-H network to drive impactful, scalable solutions in healthcare," added Leah Braddell, Chief Executive Officer of DataBiologics. "This partnership underscores our mission to empower providers with real-time, evidence-based insights that improve patient outcomes.”
The spoke network will continue to grow as the Investor Catalyst Hub expands its efforts, with applications being selected on a rolling basis. Interested organizations can visit https://investorcatalysthub.org/ to learn more or submit a membership application.
About DataBiologics
DataBiologics is at the forefront of healthcare analytics, specializing in patient outcomes tracking, regenerative medicine, and evidence-based treatment solutions. The company’s platform integrates seamlessly with healthcare providers to offer real-time insights, enabling informed decision-making that leads to improved patient care and optimized clinical outcomes.